Chemical modification of iGb3 increases IFN-gamma production by hepatic NKT cells.

[1]  P. Wang,et al.  Synthesis and structure-activity relationship study of isoglobotrihexosylceramide analogues. , 2007, The Journal of organic chemistry.

[2]  S. Fukuda,et al.  IL-21 enhances dendritic cell ability to induce interferon-gamma production by natural killer T cells. , 2007, Immunobiology.

[3]  R. Sun,et al.  The roles of innate immune cells in liver injury and regeneration. , 2007, Cellular & molecular immunology.

[4]  P. Wang,et al.  Modification of the ceramide moiety of isoglobotrihexosylceramide on its agonist activity in stimulation of invariant natural killer T cells. , 2007, Journal of medicinal chemistry.

[5]  Chi‐Huey Wong,et al.  Potent immune-modulating and anticancer effects of NKT cell stimulatory glycolipids , 2007, Proceedings of the National Academy of Sciences.

[6]  D. Pellicci,et al.  Chewing the fat on natural killer T cell development , 2006, The Journal of experimental medicine.

[7]  Dapeng Zhou.  The immunological function of iGb3. , 2006, Current protein & peptide science.

[8]  R. Steinman,et al.  Glycolipid α-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice , 2006 .

[9]  P. Wang,et al.  Synthesis and biological evaluation of α-galactosylceramide (KRN7000) and isoglobotrihexosylceramide (iGb3) , 2006 .

[10]  D. Stuart,et al.  Structure and binding kinetics of three different human CD1d–α-galactosylceramide–specific T cell receptors , 2006, The Journal of experimental medicine.

[11]  Chi‐Huey Wong,et al.  Conserved and Heterogeneous Lipid Antigen Specificities of CD1d-Restricted NKT Cell Receptors1 , 2006, The Journal of Immunology.

[12]  I. Wilson,et al.  Design of natural killer T cell activators: structure and function of a microbial glycosphingolipid bound to mouse CD1d. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Vrajesh V. Parekh,et al.  Glycolipid antigen induces long-term natural killer T cell anergy in mice. , 2005, The Journal of clinical investigation.

[14]  M. Kronenberg,et al.  Activation or anergy: NKT cells are stunned by α-galactosylceramide , 2005 .

[15]  S. Ko,et al.  α-Galactosylceramide Can Act As a Nasal Vaccine Adjuvant Inducing Protective Immune Responses against Viral Infection and Tumor1 , 2005, The Journal of Immunology.

[16]  Z. Tian,et al.  Isolation of lymphocytes and their innate immune characterizations from liver, intestine, lung and uterus. , 2005, Cellular & molecular immunology.

[17]  S. Nutt,et al.  Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer , 2005, The Journal of experimental medicine.

[18]  R. Proia,et al.  Lysosomal Glycosphingolipid Recognition by NKT Cells , 2004, Science.

[19]  M. Kronenberg,et al.  Going both ways: immune regulation via CD1d-dependent NKT cells. , 2004, The Journal of clinical investigation.

[20]  Jelena S. Bezbradica,et al.  Quantitative and Qualitative Differences in the In Vivo Response of NKT Cells to Distinct α- and β-Anomeric Glycolipids1 , 2004, The Journal of Immunology.

[21]  G. Besra,et al.  The T cell antigen receptor expressed by Valpha14i NKT cells has a unique mode of glycosphingolipid antigen recognition. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[22]  T. Yamamura,et al.  The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cells. , 2004, The Journal of clinical investigation.

[23]  H. Ljunggren,et al.  CD1d-dependent Activation of NKT Cells Aggravates Atherosclerosis , 2004, The Journal of Experimental Medicine.

[24]  M. Smyth,et al.  Glycolipid Antigen Drives Rapid Expansion and Sustained Cytokine Production by NK T Cells 1 , 2003, The Journal of Immunology.

[25]  D. Pellicci,et al.  Sequential production of interferon-gamma by NK1.1(+) T cells and natural killer cells is essential for the antimetastatic effect of alpha-galactosylceramide. , 2002, Blood.

[26]  Michael T. Wilson,et al.  Natural Killer T Cell Activation Protects Mice Against Experimental Autoimmune Encephalomyelitis , 2001, The Journal of experimental medicine.

[27]  S. Seki,et al.  Mechanisms of the Antimetastatic Effect in the Liver and of the Hepatocyte Injury Induced by α-Galactosylceramide in Mice , 2001, The Journal of Immunology.

[28]  A. Kulkarni,et al.  Glycolipid antigen processing for presentation by CD1d molecules. , 2001, Science.

[29]  M. Taniguchi,et al.  IL-18 Enhances IL-4 Production by Ligand-Activated NKT Lymphocytes: A Pro-Th2 Effect of IL-18 Exerted Through NKT Cells1 , 2001, The Journal of Immunology.

[30]  A. Herbelin,et al.  Fas/Fas Ligand Interactions Promote Activation-Induced Cell Death of NK T Lymphocytes1 , 2000, The Journal of Immunology.

[31]  L. Kaer,et al.  The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes. , 2000, International immunology.

[32]  S. Sekiya,et al.  Involvement of decidual Vα14 NKT cells in abortion , 2000 .